Literature DB >> 3547737

Freshly harvested cadaveric venous homografts as arterial conduits in infected fields.

S O Snyder, J R Wheeler, R T Gregory, R G Gayle, P K Zirkle.   

Abstract

Six patients with patent multilevel prosthetic grafts (three axillofemoral-femoral grafts, an aortobifemoral graft, an axillofemoral and femoral-anterior tibial graft, and an axillofemoral and femoral-popliteal graft) that demonstrated overt infection involving both the proximal inflow (one infrarenal aorta, five axillary arteries) and groin anastomoses required complete graft excision. Cadaveric inferior vena cava, common and external iliac, common and superficial femoral, and greater saphenous veins were harvested in conjunction with multiple organ donor procedures. Identical anatomic reconstruction within the infected fields was accomplished, with patency and distal perfusion maintained for intervals sufficient to achieve complete resolution of infection in all cases. This interval of revascularization with a venous homograft has served as a temporizing maneuver, which permitted eradication of infection and allowed subsequent reimplantation of prosthetic graft material without associated reinfection in the two instances in which it was required. Use of freshly harvested large-caliber caval, iliac, and femoral homograft veins as arterial substitutes in infected fields has not been previously reported. Case histories and a review of the venous homografting literature are included.

Entities:  

Mesh:

Year:  1987        PMID: 3547737

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  2 in total

1.  Creation of a neo-aortoiliac system from lower extremity deep and superficial veins.

Authors:  G P Clagett; B L Bowers; M A Lopez-Viego; M B Rossi; R J Valentine; S I Myers; A Chervu
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

2.  An audit of the treatment of cancer of the oesophagus.

Authors:  P M Sagar; T Gauperaa; H Sue-Ling; M J McMahon; D Johnston
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.